What does CUSIP 09061G101 represent in this 13F holders report?

CUSIP 09061G101 is the security identifier for BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock used to aggregate holder disclosures.

How many institutions held BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in Q1 2023?

544 institutional investors reported BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock for Q1 2023. Use the holders table for investor-level position and value details.

BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)

CUSIP: 09061G101

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Stock
Total 13F shares: 179,051,547
Total 13F value: $17,400,388,762
Share change: -3,393,461
Put/Call ratio: 52%
SEC-reported price per share: $97.24
Number of holders: 544
Value change: -$352,972,540
Number of buys: 260
Number of sells: 259
Shares outstanding: 192,632,743

Security key

09061G101

Report period

Q1 2023

Institutions

544

Top holders

BMRN full security history Ownership snapshot Full 13F holder table BIOMARIN PHARMACEUTICAL INC SEC filings BIOMARIN PHARMACEUTICAL INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

PRIMECAP MANAGEMENT CO/CA/

Disclosed value leader

PRIMECAP MANAGEMENT CO/CA/

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 9.1% Showing 1-6 of 15 holder rows.

Quick read

PRIMECAP MANAGEMENT CO/CA/ leads the comparable SEC ownership view at 9.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRIMECAP MANAGEMENT CO/CA/'s linked filing trail.

Comparable ownership Top 5

PRIMECAP MANAGEMENT CO/CA/ 9.1%

VANGUARD GROUP INC 9%

BlackRock Finance, Inc. 7.5%

DODGE & COX 7.5%

BAKER BROS. ADVISORS LP 4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
PRIMECAP MANAGEMENT CO/CA/	13F Company 13F	9.1%	$1,819,443,098 17,580,859 shares	—	31 Dec 2022
VANGUARD GROUP INC	13F Company 13F	9%	$1,797,112,129 17,365,080 shares	—	31 Dec 2022
BlackRock Finance, Inc.	13F Company 13F	7.5%	$1,504,764,369 14,540,191 shares	—	31 Dec 2022
DODGE & COX	13F Company 13F	7.5%	$1,488,565,284 14,383,663 shares	—	31 Dec 2022
BAKER BROS. ADVISORS LP	13F Company 13F	4%	$788,644,924 7,620,494 shares	—	31 Dec 2022
Capital Research Global Investors	13F Company 13F	2.9%	$584,800,024 5,651,001 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

544

179,051,547

Rows available

544

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

544

Q1 2023 holders

544

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %